FDA Drug recall D-0118-2017
Ramipril Capsules, USP, 1.25 mg, 30-count bottle, Rx only, Manufactured by: Arrow Pharm (Malta) Ltd., Birzebbugia, BBG3000, Malta
- FDA Drug
- Class III
- ongoing
- Published 2016-11-09
On 2016-11-09 the FDA classified a Class III recall of Ramipril Capsules, USP, 1.25 mg, 30-count bottle, Rx only, Manufactured by: Arrow Pharm (Malta) Ltd., Birzebbugia, BBG3000, Malta by Actavis Laboratories Fl, citing labeling: Incorrect or Missing Lot And/or Exp Date: Bottles labeled with the incorrect expiration date of 03/18 rather than 09/17.
Read the official FDA Drug notice
| Agency | FDA Drug |
|---|---|
| Recall number | D-0118-2017 |
| Classification | Class III |
| Status | ongoing |
| Initiated | 2016-08-30 |
| Published | 2016-11-09 |
| Last updated | 2026-09-13 11:51 UTC |
| Company | Actavis Laboratories Fl |
| Distribution | US |
Product
Ramipril Capsules, USP, 1.25 mg, 30-count bottle, Rx only, Manufactured by: Arrow Pharm (Malta) Ltd., Birzebbugia, BBG3000, Malta; Distributed by: Actavis Pharma, Inc., Parsippany, NJ 07054, NDC 16252-570-30.
Reason
Labeling: Incorrect or Missing Lot And/or Exp Date: Bottles labeled with the incorrect expiration date of 03/18 rather than 09/17.
Identifiers
| code_info | Lot #: 1136091A, Incorrectly Labeled Exp: 03/18 |
|---|
Status history
No status changes recorded since RecallRadar first saw this recall on 2026-09-13 11:51 UTC. Current status: ongoing.
Source
Official record: https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0118-2017%22
RecallRadar indexes public recall notices from the FDA, USDA FSIS, and CPSC. The official agency notice is the authoritative source. Always confirm details at the linked source before acting.